BIOTABS LIFE SCIENCES
 
Future goals
   
We are engaged in the process of starting NCE research to discovering, developing and addressing all gray areas of Pharmaceutical industry.
 
 

Therapeutic Areas

Metabolic disorders:

Universally, Diabetes is one of the leading causes of death, though there are several treatment options available to tackle this menace. Many around the globe suffer, and endure this great affliction, and the woes caused while treating this problem are aplenty. A need persists for effective and safety therapies, where insulin resistance and obesity are handled in such a way that such treatments are not just palliative but curative.

Bacterial Infections:

The prevalence of hospital acquired infections is growing rapidly as drug-resistant bacteria poses great threats, causing complexity in treating them. We will explore, identify, and evaluate all possible fields to find better ways to combat such infections with products of enhanced efficacy and tolerability profiles, so that such infections are no more drug- resistant.

 
     
 

Pain & Inflammation:

The pathetic state of chronic and acute pain is growing steadily with our valetudinarian population, though the symptoms and diagnosis rates improve. The need for treating such ailments clubbed with both safety and tolerance remains vital. We are dedicated to developing new products with added efficacy with far less side-effects in treating them.